News

News

No. Title Written by Date Read
18 STcube, Selected by Pharma Tech Outlook TOP 10 Immunotherapy Solution Companies Admin 21.07.19 206
17 A successful presentation of a First-in-Class drug targeting ‘BTN1A1’ at the AACR 2021 Admin 21.04.16 387
16 Research on STCube’s Small Molecule Immunotherapeutic Agent for Pancreatic Cancer Published in Prestigious Scientific Journal Admin 20.12.09 4,307
15 STCube, Inc. Obtains U.S. Patent for Proprietary Anti-PD-1 Antibody Admin 20.10.30 389
14 Enter into CDMO Agreement with Samsung Biologics /Eyes of CEO/Hankyung TV Admin 20.08.13 821
13 STCube signs additional development and manufacturing agreement with Samsung Biologics Admin 20.07.12 453
12 STCube Presents Data on Its Proprietary PD-1 Antibody at AACR Admin 20.06.23 537
11 STCube Applies for a U.S. Patent on the COVID-19 Anti-viral Treatment Using 'STT-003' Admin 20.03.30 435
10 STCube Initiates a CRO Contract for Development of COVID-19 Treatment Using ‘STT-003’ Admin 20.03.23 443
9 STCube Publishes Research Paper on Its Antibody to Immune-checkpoint Inhibitor PD-1 in Cancer Research, an International Academic Journal Admin 20.03.12 455